GSK is upgrading their small molecule registration system to allow end users to fully specify stereochemistry in molecules without intervention from registrars. This will use the v3000 mol format to accurately represent stereochemistry. However, downstream systems currently rely on v2000 format or standard SMILES, causing inconsistent search results for stereochemistry queries. GSK plans to upgrade databases and services to use v3000 format as the standard to ensure consistent searching across applications by mid-2016. This will also help meet future European legislation requirements for describing medicines.